Single-dose, ready-to-use injectable formulations Grant US-11819499-B2 United States of America 21 Nov 2023
Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors Grant US-11780823-B2 United States of America 10 Oct 2023
5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof Grant US-11713320-B2 United States of America 01 Aug 2023
Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof Grant US-11697649-B2 United States of America 11 Jul 2023